Combining toll-like receptor agonists with immune checkpoint blockade affects antitumor vaccine efficacy
Background
T cell checkpoint receptors are expressed when T cells are activated, and modulation of the expression or signaling of these receptors can alter the function of T cells and their antitumor efficacy. We previously found that T cells activate…